TheEdgeResearch
Home / Stocks / HSTI

High Sierra Technologies, Inc. (HSTI)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$1.40 ▲ +0.00%
Market Cap
$29.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.07
52-Wk Range
1.25-1.4
CEO
Vincent C. Lombardi
Country
US
Currency
USD

High Sierra Technologies, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Reno, NV, US. The stock last traded at $1.40, up 0.00% on the session, giving a market capitalisation of $29.3M. On trailing twelve-month figures it carries a trailing P/E of -22.76, a net margin of 0.0%. Its beta of -0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-22.76
Price / Sales
0.00
Price / Book
-24.65
EV / EBITDA
238.79
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.58
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2007-09-04
Headquarters
Reno, NV, US
About High Sierra Technologies, Inc.

High Sierra Technologies, Inc. specializes in the creation of patents and related products for the processing of recreational cannabis and industrial hemp. Its intellectual property encompasses innovations for producing low-odor cannabis and hemp, suitable either for direct consumption through smoking or as foundational materials for manufacturing a variety of low-odor or flavored cannabis and hemp goods. The company operates out of Reno, Nevada.

Comparable companies

High Sierra Technologies, Inc. is most often compared with the following Healthcare names:

AVCNFCAAOFCNTMFCWBHFEOFBFMEDIFNXSCFROMJFVYYRFWOWU
More research on HSTI
HSTI technical analysis HSTI TheEdge Score Compare against peers
Open full interactive analysis & DCF →